PMID- 28672073 OWN - NLM STAT- MEDLINE DCOM- 20180604 LR - 20220311 IS - 1520-6394 (Electronic) IS - 1091-4269 (Print) IS - 1091-4269 (Linking) VI - 34 IP - 12 DP - 2017 Dec TI - Prediction of treatment outcomes to exercise in patients with nonremitted major depressive disorder. PG - 1116-1122 LID - 10.1002/da.22670 [doi] AB - BACKGROUND: Only one-third of patients with major depressive disorder (MDD) achieve remission with initial treatment. Consequently, current clinical practice relies on a "trial-and-error" approach to identify an effective treatment for each patient. The purpose of this report was to determine whether we could identify a set of clinical and biological parameters with potential clinical utility for prescription of exercise for treatment of MDD in a secondary analysis of the Treatment with Exercise Augmentation in Depression (TREAD) trial. METHODS: Participants with nonremitted MDD were randomized to one of two exercise doses for 12 weeks. Participants were categorized as "remitters" (